Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Prostate cancer
by Highest Patent Value in the China in 2019

The Prostate cancer top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Prostate cancer Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A cancer of the prostate gland, a part of the male reproductive system.
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 5.73 M
2
Medicine,Health care,Drug development,
...[+2]
Avg patent value: 5.53 M
3
Drug,Health care,Antineoplastic Drugs,
...[+2]
Avg patent value: 4.42 M
4
Avg patent value: 3.26 M
5
Avg patent value: 3.19 M
6
Suzhou Kaixi Pharmaceutical Co Ltd
Avg patent value: 3.11 M
7
Avg patent value: 2.58 M
8
Drug,Health care,Pharmacy,
...[+1]
Avg patent value: 2.55 M
9
Avg patent value: 2.52 M
10
Avg patent value: 2.46 M
11
Avg patent value: 2.23 M
12
Avg patent value: 2.03 M
13
Icotinib Hydrochloride,Health care,Drug,
...[+2]
Avg patent value: 1.99 M
14
Avg patent value: 1.92 M
15
Avg patent value: 1.50 M
16
Genome,Biology,Health care,
...[+2]
Avg patent value: 1.45 M
17
Avg patent value: 1.42 M
18
Avg patent value: 1.30 M
19
Avg patent value: 1.16 M
20
Avg patent value: 1.15 M
Page generation time: Jul 19 2025